miR-378a-3p Promotes M2 Macrophage Polarization, Improving Cardiac Repair After Infarction Via Trem1
Background
Early detection and effective treatment for Acute Myocardial Infarction (AMI) remain critical, as post-infarction cardiac remodeling often leads to heart failure. The inflammatory response following AMI, particularly macrophage polarization dynamics, profoundly influences cardiac repair outcomes. While M1 macrophages exacerbate inflammation, M2 macrophages promote healing. However, the precise regulatory roles of microRNAs in orchestrating this crucial macrophage shift for cardiac repair are largely undefined, representing a significant therapeutic gap.
Study Design
Researchers conducted an integrated analysis of GEO datasets and performed experimental validation in hypoxic Raw264.7 cells and a mouse AMI model. In vitro, miR-378a-3p mimics were administered to cells. In vivo, miR-378a-3p agomir was delivered to mice with induced AMI. Primary endpoints included assessing macrophage polarization (M1 vs. M2), inflammatory cytokine production, and evaluating cardiac function and remodeling. The study also investigated the mechanistic interaction between miR-378a-3p and its target, Trem1, using overexpression experiments.
Results
Integrated GEO datasets and experimental validation revealed that miR-378a-3p is significantly downregulated following ischemic injury. In both hypoxic Raw264.7 cells and the mouse AMI model, administration of miR-378a-3p mimics or miR-378a-3p agomir effectively suppressed M1 macrophage polarization. This intervention also attenuated inflammatory cytokine production, leading to markedly improved cardiac function and remodeling after AMI. Mechanistically, miR-378a-3p was found to directly bind the 3'UTR of Trem1 mRNA. > Overexpression of Trem1 reversed the anti-inflammatory and pro-repair effects of miR-378a-3p, definitively confirming Trem1 as a functional target in this pathway. This establishes the miR-378a-3p/Trem1 axis as a critical regulator of post-infarction inflammation.
Key Findings
- miR-378a-3p is significantly downregulated following ischemic injury in AMI.
- Administration of miR-378a-3p suppressed M1 macrophage polarization in vitro and in vivo.
- miR-378a-3p attenuated inflammatory cytokine production after AMI.
- miR-378a-3p markedly improved cardiac function and remodeling in a mouse AMI model.
- miR-378a-3p directly binds the 3'UTR of
Trem1mRNA, withTrem1overexpression reversing its beneficial effects.
Why It Matters
This study unveils the miR-378a-3p/Trem1 axis as a novel and critical regulator of post-infarction inflammation, offering a promising therapeutic target for Acute Myocardial Infarction (AMI). By promoting a shift from pro-inflammatory M1 to pro-healing M2 macrophages, miR-378a-3p could mitigate acute cardiac injury and improve long-term outcomes for patients. The identification of miR-378a-3p as a therapeutic candidate opens avenues for developing microRNA-based interventions to modulate the inflammatory response and enhance cardiac repair. While currently preclinical, this research provides a strong mechanistic foundation for future translational studies aimed at developing a usable protocol for AMI patients.
mir-378a-3p
acute-myocardial-infarction
cardiac-repair
macrophage-polarization
inflammation
trem1